Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis

Arthritis and Rheumatism

Volumn 56, Issue 12, 2007, Pages 4203-4215

  Distler, Jörg H W ^a,b   Jüngel, Astrid ^a   Pileckyte, Margarita ^c   Zwerina, Jochen ^b   Michel, Beat A ^a   Gay, Renate E ^a   Kowal Bielecka, Otylia ^d   Matucci Cerinic, Marco ^e   Schett, Georg ^b   Marti, Hugo H ^f   Gay, Steffen ^a   Distler, Oliver ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c KAUNAS UNIVERSITY OF MEDICINE HOSPITAL   (Lithuania)

^d MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^e UNIVERSITY OF FLORENCE   (Italy)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT; COLLAGEN TYPE 1; DEFEROXAMINE; FIBRONECTIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 3; THROMBOSPONDIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKIN CELL; SUBTRACTIVE HYBRIDIZATION; SYSTEMIC SCLEROSIS; UPREGULATION;

ANIMALS; BIOPSY; CELL HYPOXIA; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; OXYGEN; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SKIN; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 37149006718     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23074     Document Type: Article

References (30)

1. Distler JH, Wenger RH, Gassmann M, Kurowska M, Hirth A, Gay S, et al. Physiologie responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis [review]. Arthritis Rheum 2004;50:10-23.
2. 2- regulated gene expression. FASEB J 2002;16:1151-62.
3. Generini S, Matucci-Cerinic M. Raynaud's phenomenon and vascular disease in systemic sclerosis. Adv Exp Med Biol 1999;455:93-100.
4. Varga J, Bashey RI. Regulation of connective tissue synthesis in systemic sclerosis. Int Rev Immunol 1995;12:187-99.
5. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-6.
6. Distler O, Distler JH, Scheid A, Acker T, Hirth A, Rethage J, et al. Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis. Circ Res 2004;95:109-16.
7. Distler JH, Wenger RH, Gassmann M, Kurowska M, Hirth A, Gay S, et al. Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2004;50:10-23.
8. Distler JH, Jungel A, Caretto D, Schulze-Horsel U, Kowal-Bielecka O, Gay RE, et al. Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells. Arthritis Rheum 2006;54:214-25.
9. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
10. Ryan HE, Lo J, Johnson RS. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J 1998;17:3005-15.
11. Stroka DM, Burkhardt T, Desbaillets I, Wenger RH, Neil DA, Bauer C, et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 2001;15:2445-53.
12. Camenisch G, Tini M, Chilov D, Kvietikova I, Srinivas V, Caro J, et al. General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the hypoxia-inducible factor 1α. FASEB J 1999;13:81-8.
13. Zhang J, Underwood LE, D'Ercole AJ. Hepatic mRNAs up-regulated by starvation: an expression profile determined by suppression subtractive hybridization. FASEB J 2001;15:1261-3.
14. Distler JH, Jungel A, Kowal-Bielecka O, Michel BA, Gay RE, Sprott H, et al. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum 2005;52:856-64.
15. Barghorn A, Komminoth P, Bachmann D, Rutimann K, Saremaslani P, Muletta-Feurer S, et al. Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression. J Pathol 2001;194:451-8.
16. Wanner RM, Spielmann P, Stroka DM, Camenisch G, Camenisch I, Scheid A, et al. Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation. Blood 2000;96:1558-65.
17. Hong KH, Yoo SA, Kang SS, Choi JJ, Kim WU, Cho CS. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts. Clin Exp Immunol 2006;146:362-70.
18. O'Brien ER, Bennett KL, Garvin MR, Zderic TW, Hinohara T, Simpson JB, et al. βig-h3, a transforming growth factor-β-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. Arterioscler Thromb Vasc Biol 1996;16:576-84.
19. Billings PC, Herrick DJ, Kucich U, Engelsberg BN, Abrams WR, Macarak EJ, et al. Extracellular matrix and nuclear localization of βig-h3 in human bladder smooth muscle and fibroblast cells. J Cell Biochem 2000;79:261-73.
20. Hashimoto K, Noshiro M, Ohno S, Kawamoto T, Satakeda H, Akagawa Y, et al. Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/βig-h3) that binds to collagen. Biochim Biophys Acta 1997;1355:303-14.
21. LeBaron RG, Bezverkov KI, Zimber MP, Pavelec R, Skonier J, Purchio AF. βIG-H3, a novel secretory protein inducible by transforming growth factor-β, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J Invest Dermatol 1995;104:844-9.
22. Pilewski JM, Liu L, Henry AC, Knauer AV, Feghali-Bostwick CA. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol 2005;166:399-407.
23. Knauer AV, Medsger TA Jr, Wright TM, Feghali CA. Insulin-like growth factor binding proteins contribute to the increased extracellular matrix production by fibroblasts from patients with systemic sclerosis (SSc) [abstract]. Arthritis Rheum 2001;44 Suppl 9:S378.
24. Corpechot C, Barbu V, Wendum D, Kinnman N, Rey C, Poupon R, et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 2002;35:1010-21.
25. Falanga V, Tiegs SL, Alstadt SP, Roberts AB, Sporn MB. Transforming growth factor-β: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J Invest Dermatol 1987;89:100-4.
26. Orphanides C, Fine LG, Norman JT. Hypoxia stimulates proximal tubular cell matrix production via a TGF-β1-independent mechanism. Kidney Int 1997;52:637-47.
27. Kung AL, Zabludoff SD, France DS, Freedman SJ, Tanner EA, Vieira A, et al. Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway. Cancer Cell 2004;6:33-43.
28. Kaelin WG Jr. The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing. Biochem Biophys Res Commun 2005;338:627-38.
29. Huber LC, Distler JH, Michel BA, Gay RE, Kalden JR, Matucci-Cerinic M, et al. Inhibition of histone deacetylases reduces the TGFβ-stimulated production of extracellular matrix proteins of skin fibroblasts from patients with systemic sclerosis [abstract]. Arthritis Rheum 2005;52 Suppl 9:S463.
30. Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 2001;7:437-43.